The FDA has received 5,611 adverse event reports for cats that name Buprenorphine.
- 5,611 reports name Buprenorphine in cats, which is 3.7% of all 151,164 cat reports. A report counts under every active ingredient it names.
- 34% are marked serious and 14% record a death or euthanasia; across all cat reports those figures are 27% and 9.4%.
- 4.6% are complaints that the product did not work (19% across all cat reports).
- The clinical signs reported most are behavioural disorder, dilated pupils and not eating.
- The FDA lists 2 approved animal drug applications containing Buprenorphine for cats, the earliest approved in 2014.
- None of this is a rate. The FDA data does not record how many cats were given Buprenorphine, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All cat reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 1,931 | 34% | 27% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 763 | 14% | 9.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 260 | 4.6% | 19% |
| Seizurea seizure or convulsion is among the clinical signs | 161 | 2.9% | 2.6% |
| Not used per labelthe report says the product was not used the way its label directs | 3,158 | 56% | 33% |
Where on the body do the reported signs sit?
Not on the body: Whole body 27%
- Behaviour37%behavioural disorder, hyperactivity, dysphoria, not sleeping and 4 more
- Whole body27%death, lethargy, fever, hyperthermia and 4 more
- Stomach and gut19%not eating, anorexia, vomiting, weight loss and 1 more
- Eyes7.9%dilated pupils
- Thirst and urination3.2%not drinking
- Brain and nerves3.1%ataxia
- Blood and organ tests2.3%other abnormal test result
Each figure is a share of sign mentions among the 25 signs reported most for Buprenorphine in cats. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Behavioural disorder963 17%
- Dilated pupils740 13%
- Not eating684 12%
- Hyperactivity570 10%
- Dysphoria522 9.3%
- Anorexia471 8.4%
- Death422 7.5%
- Lethargy393 7.0%
Reports received per year
Is it approved for cats?
The FDA lists 2 approved animal drug applications containing Buprenorphine for cats, the earliest approved in 2014.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| SimbadolZoetis Inc. | Injectable Solution RX | Cat | 2014 | 141-434 |
| ZorbiumElanco US Inc. | Transdermal Solution RX | Cat | 2022 | 141-547 |
From the FDA record for Simbadol: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Emodepside in cats5,732
- Velagliflozin in cats4,798
- Bexagliflozin in cats4,053
- Ketamine in cats4,012
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.